Success stories

Our Success stories in 2017

Finished projects under fundraising process

Cornea
  • IVD project: diagnose of keratoconus
  • 1 M€ raised in Nov 2020
  • Investors: Capital Cell, Family Offices and Business Angels
Oxolife
  • Pharma project: treatment of women infertility
  • 5 M€ raised in May 2020
  • Investors: Inveready, CDTI, Capital Cell, Family Offices
Corify Care
  • Medtech project: stratification of patients suffering from atrial fibrillation
  • 1 M€ raised in January 2019
  • Investors: Family offices and EU funds
Apta Targets
  • Pharma project: new aptamer for ischemic stroke
  • 4,5 M€ raised in May 2017
  • Investors: Caixa Capital Risc and Inveready
Anaconda Brain
  • IVD project: diagnose of keratoconus
  • 1 M€ raised in Nov 2020
  • Investors: Capital Cell, Family Offices and Business Angels
Peptomyc
  • Biotech project: recombinant protein for NSCLC and TNBC
  • 4,2 M€ raised in July 2017
  • Investors: ALTA Life Sciences and Healthequity
  • IVD project: new biomarker for cardiovascular ischemia
  • 3,1 M€ raised in October 2017
  • Investors: Caixa Capital Risc and Healthequity

Current projects under fundraising process

Signed deals Sector Round size Year Investors
AptaTargets Pharma 4,5 M€ 2017 Caixa Capital Risc, Inveready
Anaconda Biomed Medtech 15 M€ 2017 Ysios, Omega, Innogest, BSabadell
Peptomyc Biotech 4,2 M€ 2017 ALTA Life Sciences, Healthequity
GlyCardial Diagnostics IVD 3,1 M€ 2017 Caixa Capital Risc, Healthequity
MJN Neuroserveis Medtech 750 k€ 2018 Ship2B and Family Offices
Cornea Project IVD 300 k€ 2018 Industrial partner
Corify Care Medtech 1 M€ 2019 Family Office and EU Funds
Oxolife Pharma 300 k€ 2019 Family Office
Cornea Project IVD 300 k€ 2019 Family Office
LiverScreen Project Medtech 8,5 M€ 2019 EU Funds
CreatSens IVD 750 k€ 2019 EU Funds
ABLE Human Motion Medtech 2,5 M€ 2019 EU Funds
Peptomyc Pharma 11,4 M€ 2020 AurorA Science, ALTA LS, Healthequity
Oxolife Pharma 5 M€ 2020 Inveready, CDTI, crowdfunding
CORNEA Project IVD 1 M€ 2020 Capital Cell and BAs